Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
Inequities observed in telemedicine use for cancer care during COVID-19 pandemic
As telemedicine use increased during the COVID-19 pandemic, Black patients with cancer had lower usage levels than white patients, according to study results presented during a virtual press briefing ahead of the ASCO Annual Meeting.
Cancer organizations issue recommendations to increase clinical trial diversity
ASCO and the Association of Community Cancer Centers have jointly developed recommendations for improving equity, diversity and inclusion in cancer clinical trials.
Log in or Sign up for Free to view tailored content for your specialty!
Cancer death rates remain highest among Black individuals vs. other racial, ethnic groups
Despite a decrease in cancer mortality among Black individuals between 1999 and 2019, cancer death rates remained highest among Black men and women compared with any other racial and ethnic group.
Medicaid expansion linked to survival gain, reduced disparities among patients with cancer
The expansion of Medicaid under the Affordable Care Act correlated with an increase in 2-year OS rates among patients newly diagnosed with cancer, according to study results published in JNCI: Journal of the National Cancer Institute.
Bitter taste receptors may hold potential as chemotherapeutic targets
The body has 25 types of functional bitter taste receptors, but tasting is not their only function.
Lack of guideline-concordant treatment for early-stage non-small cell lung cancer common
A substantial proportion of patients with resected early non-small cell lung cancer who consented to an adjuvant therapy screening trial did not receive adequate lymph node dissection or adjuvant chemotherapy, according to study results.
Top headlines in Lung Cancer: early lung cancer detection; NSCLC immunotherapy; and more
In this edition, early lung cancer detection improves survival rates; incidental respiratory findings on low-dose CT lung cancer screening common; certain patients may derive more benefit from immunotherapy for non-small cell lung cancer and more.
Entrectinib induces durable, intracranial responses in NTRK fusion-positive solid tumors
Entrectinib demonstrated durable systemic and intracranial responses in patients with NTRK fusion-positive solid tumors, according to study results published in Clinical Cancer Research.
Should patients with cancer be screened for distress during their first appointment with an oncologist?
Although most cancer centers may not screen every patient at every visit, I believe in it whole-heartedly, and this is what we do at Rush University. If we believe in the value of asking patients how they are doing, it’s hard to justify excluding certain visits from this practice, particularly considering we aren’t very good about predicting when any individual patient might be struggling.
‘Communication is key’ to reduce suicide risk after cancer diagnosis
Studies consistently have shown patients with cancer have a higher risk for suicide than the general public.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read